Key Findings of DRCR Protocol AC Study

Experts discuss the recent DRCR Protocol AC study comparing aflibercept monotherapy vs bevacizumab first therapy for patients with diabetic macular edema (DME).

Related Keywords

Veeral Sheth ,Jonathan Jonisch ,Ehsan Rahimy , ,New England Journal ,Diabetic Macular Edema ,Dme ,Age Related Macular Degeneration ,Amd ,Diabetes ,Anti Vegf ,Aflibercept ,Bevacizumab ,First Line ,